These results indicate that the CPT/BTZ regimen acts via the non‐canonical NF‐κB as well as intrinsic/extrinsic apoptotic pathways to induce cell death in MM cells, and may represent an effective strategy in the setting of bortezomib resistance. Here, NFKB1 is linked to Miyoshi myopathy.